509 A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low dose cyclophosphamide for patients with advanced solid tumorsYasuhiro Hijikata, Hiroaki Ogata, Teiji Okazaki et al.|European Journal of Cancer|2015Cited by 0
Phase I Clinical Trial of Cancer Vaccine Combined with Chemotherapy Targeting both Tumor Antigen and Immune Tolerance Against Advanced Solid TumorsMutsunori Murahashi, Kenzaburo Tani, Tomotoshi Marumoto et al.|Annals of Oncology|2012Cited by 0